Hantz Financial Services’s Verona Pharma VRNA Stock Holding History

Hantz Financial Services’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,528	Closed	-$163K	–	2548
2025 Q3	$163K	Buy	1,528 +1,404	+1,132%	+$147K	﹤0.01%	813
2025 Q2	$12K	Buy	+124	New	+$9.18K	﹤0.01%	1459

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Hantz Financial Services's VRNA Position: Q4 2025 in Review

Hantz Financial Services sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,528 shares — an estimated $163K sold.

Hantz Financial Services first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $163K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Hantz Financial Services reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Hantz Financial Services sold 1,528 Verona Pharma shares in Q4 2025, an estimated $163K.
Hantz Financial Services first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Hantz Financial Services's Verona Pharma position peaked at $163K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Hantz Financial Services's 13F filing for Q4 2025, filed 9 Feb 2026.